stella
beta
HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC — Stella
Recruiting
Back to BCLC Stage B Hepatocellular Carcinoma trials
Trial locations
(1 site)
China
The first hospital of China medical university, Shenyang, Liaoning
View full record on ClinicalTrials.gov